Professor, Pathology and Immunology, Washington University School of Medicine
Pathology
Dr. Elizabeth M. Brunt, MD
|
|
Give Review
Elizabeth Brunt is an expert in the field of Pathology. Doctor Elizabeth M. Brunt, MD is also a published MD. She has 97 publication published. The most recent publication is: Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI... She accepts Medicare.
Publications
- Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI...
- The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
- Pathological Features of Fatty Liver Disease.
- Histological features and severity of oxaliplatin-induced liver injury and clinical associations.
- Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities, but not inflammation and injury in mice.
- Characterization of Inflammatory (Lymphoepithelioma-like) Hepatocellular Carcinoma: A Study of 8 Cases.
- SALL4 Immunoreactivity Predicts Prognosis in Western Hepatocellular Carcinoma Patients but Is a Rare Event: A Study of 236 Cases.
- Relationship Between Changes in Serum Levels of Keratin 18 and Changes in Liver Histology in Children and Adults With Nonalcoholic Fatty Liver Disease.
- Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
- Pathology Of The Liver Sinusoids.
- Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis.
- Estimation of Fish and É-3 Fatty Acid Intake in Pediatric Nonalcoholic Fatty Liver Disease.
- Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis.
- CD36 deletion reduces VLDL secretion, modulates liver prostaglandin levels and exacerbates hepatic steatosis in ob/ob mice.
- Multi-SNP Analysis of GWAS Data Identifies Pathways Associated with Nonalcoholic Fatty Liver Disease.
- Estimation of Fish And Omega-3 Fatty Acid Intake In Pediatric Nonalcoholic Fatty Liver Disease.
- Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease.
- Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas.
- Parenchymal alterations in cirrhotic livers in patients with hepatopulmonary syndrome or portopulmonary hypertension.
- Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
- Surgical assessment of significant steatosis in donor livers: The beginning of the end for frozen section analysis?
- Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis.
- Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the trea...
- Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
- Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma.
- Divergent quasispecies evolution in de novo hepatitis C virus infection associated with bone marrow transplantation.
- Keratin 19 Epithelial Patterns in Cirrhotic Stroma Parallel Hepatocarcinogenesis.
- The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis vs. drug-induced liver injury.
- Endpoints and clinical trial design for nonalcoholic steatohepatitis.
- Misuse of scoring systems.
- Response to letter submitted mar 18 re: HEP10-1726R1.
- Hepatic steatosis, inflammation, and ER stress in mice maintained long-term on a very low-carbohydrate ketogenic diet.
- Fighting the bushfire in HCC trials.
- "Pardon the interruption": comments on the International Liver Cancer Association Fourth Annual Conference, 2010. Is there really no role for liver biopsy in...
- Non-alcoholic fatty liver disease: what's new under the microscope?
- Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.
- Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts.
- Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.
- Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.
- American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis.
- Short- and long-term outcomes after steatotic liver transplantation.
- Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress.
- Liver biopsy diagnosis of hepatitis: clues to clinically-meaningful reporting.
- Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice.
- Hepatic expression of cell death-inducing DFFA-like effector C in obese subjects is reduced by marked weight loss.
- Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility.
- Nonalcoholic fatty liver disease: pathology and pathogenesis.
- Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer.
- Histopathology of non-alcoholic fatty liver disease.
- Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.
- Best cases from the AFIP: multiple gastric carcinoids.
- Familial adenomatous polyposis-associated ampullary adenoma: response to chemotherapy for concurrent metastatic adenocarcinoma.
- Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic ste...
- Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
- Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.
- Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?
- Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.
- The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury.
- Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models.
- Do you see what I see? The role of quality histopathology in scientific study.
- Pathology of nonalcoholic fatty liver disease.
- The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis.
- Epstein-Barr virus hepatitis: diagnostic value of in situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patie...
- AAV vector integration sites in mouse hepatocellular carcinoma.
- Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
- Pathology of fatty liver disease.
- Sustained resolution of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy.
- Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma.
- Diabetic hepatosclerosis: diabetic microangiopathy of the liver.
- Nonalcoholic steatohepatitis: pathologic features and differential diagnosis.
- Pathology of hepatic iron overload.
- Hepatocellular progenitor cell tumor of the gallbladder: a case report and review of the literature.
- Expression of HSP47, a collagen-specific chaperone, in normal and diseased human liver.
- Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C.
- Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.
- Chemoprevention of hepatocellular carcinoma: use of tamoxifen in an animal model of hepatocarcinogenesis.
- Benign hepatocellular tumors (adenomatosis) in nonalcoholic steatohepatitis: a case report.
- Pathological features of NASH.
- Metabolic storage diseases: amyloidosis.
- Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens.
- Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.
- Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.
- Evaluating liver disease in chronic hepatitis C--the role of the liver biopsy.
- Hepatic iron overload in blacks and whites: a comparative autopsy study.
- Orlistat in the treatment of NASH: a case series.
- Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease.
- Budd-Chiari syndrome and hepatocellular carcinoma: a case report and review of the literature.
- Expression of P-glycoprotein and C-MOAT in human hepatocellular carcinoma: detection by immunostaining.
- Evolution of hepatitis C viral quasispecies after liver transplantation.
- Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
- Hepatocellular carcinoma: predisposing conditions and precursor lesions.
- Alcoholic and nonalcoholic steatohepatitis.
- Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
Schools
University of Texas At Galveston Medical Branch
Barnes Jewish Hospital
St John39s Mercy Med Center
Doctors Specialties
- Anatomic Pathology
- Clinical Pathology
- Pathology
Accepted Insurances
Education
-
Washington University - Barnes-Jewish Hospital -
University of Texas Medical Branch
Hospital
-
Barnes-Jewish Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275547754 |
| Last Name Of The Provider | BRUNT |
| First Name Of The Provider | ELIZABETH |
| View All |
Similar Doctors
|
|
Dr. Maria F. Serrano, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharda Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Andrey S. Shaw
This Doctor is OpenDoctor Recommended.
|
|
|
Anagh Vora |
|
|
Dr. Dengfeng Cao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madhu G. Bahl, MD |
|
|
Dr. Christine M. Janney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Humphrey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yolande P. Blaise, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy J. Phillips, MD |
|
|
Dr. Linda J. Shires, MD |
|
|
Dr. Veronica D. Zotos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen E. Lister, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James R. Miller, MD |
|
|
Dr. Miguel A. Guzman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne C. Lind, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ladan Fazlollahi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabriel A. Bien-Willner, MD |
|
|
Dr. Jena B. Hudson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam E. Meyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juliette B. Scantlebury, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lii-Mei B. Tsai, MD |
|
|
Dr. Bijal A. Parikh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vinit V. Patil, MD |